Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis
- PMID: 23933765
- DOI: 10.1038/bmt.2013.114
Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis
Abstract
Depletion of naive T cells from donor leukapheresis products (LPs) aims at the reduction of alloreactivity, while preserving memory T-cell reactivity (for example, to pathogens). This study established the immunomagnetic depletion procedure under clean room conditions using CD45RA beads and analyzed LPs of six donors for cell composition and functional immune responses. CD45RA depletion resulted in 3.4-4.7 log (median 4.4) reduction of CD45RA(+) T cells, thereby eliminating naive and late effector T cells. B cells were also completely removed, whereas significant proportions of NK cells, monocytes and granulocytes persisted. CD45RA-depleted LPs contained effector and central memory CD4(+) and CD8(+) T cells that showed sustained IFN-γ secretion to CMV, EBV, Aspergillus and Candida Ags. Alloreactivity was measured in MLRs between donors with complete HLA-mismatch. Alloreactive CD8(+) T cells were strongly reduced (median >1-log) upon CD45RA depletion, whereas alloreactive CD4(+) T cells persisted in significant numbers. In conclusion, clinical grade depletion of CD45RA(+) naive T cells from donor LPs is feasible and highly efficient. The depleted products show sustained CD4(+) and CD8(+) T-cell reactivity to pathogens and effectively reduced CD8-mediated alloreactivity. Prophylactic and preemptive infusions after allogeneic SCT may improve T-cell reconstitution and pathogen-specific immunosurveillance, along with lower risk of inducing GVHD.
Similar articles
-
Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.Cytotherapy. 2018 Apr;20(4):532-542. doi: 10.1016/j.jcyt.2018.01.006. Epub 2018 Mar 2. Cytotherapy. 2018. PMID: 29500069
-
Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.Int J Mol Sci. 2019 Mar 20;20(6):1415. doi: 10.3390/ijms20061415. Int J Mol Sci. 2019. PMID: 30897843 Free PMC article.
-
Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.Haematologica. 2011 Jul;96(7):1024-32. doi: 10.3324/haematol.2010.037481. Epub 2011 Apr 12. Haematologica. 2011. PMID: 21486863 Free PMC article.
-
Properties of end-stage human T cells defined by CD45RA re-expression.Curr Opin Immunol. 2012 Aug;24(4):476-81. doi: 10.1016/j.coi.2012.04.001. Epub 2012 May 1. Curr Opin Immunol. 2012. PMID: 22554789 Review.
-
Selective depletion of naïve T cells by targeting CD45RA.Front Oncol. 2023 Jan 27;12:1009143. doi: 10.3389/fonc.2022.1009143. eCollection 2022. Front Oncol. 2023. PMID: 36776371 Free PMC article. Review. No abstract available.
Cited by
-
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.Front Bioeng Biotechnol. 2022 Apr 4;10:867042. doi: 10.3389/fbioe.2022.867042. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35480981 Free PMC article.
-
Removal of CD276+ cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD.Bone Marrow Transplant. 2021 Oct;56(10):2336-2354. doi: 10.1038/s41409-021-01307-9. Epub 2021 May 11. Bone Marrow Transplant. 2021. PMID: 33976380 Free PMC article.
-
Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies.Bone Marrow Transplant. 2015 Jul;50(7):968-77. doi: 10.1038/bmt.2014.324. Epub 2015 Feb 9. Bone Marrow Transplant. 2015. PMID: 25665048 Free PMC article.
-
Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads.Bone Marrow Transplant. 2015 Oct;50(10):1358-64. doi: 10.1038/bmt.2015.135. Epub 2015 Jun 15. Bone Marrow Transplant. 2015. PMID: 26076125
-
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.JCI Insight. 2018 May 17;3(10):e99048. doi: 10.1172/jci.insight.99048. eCollection 2018 May 17. JCI Insight. 2018. PMID: 29769444 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials